Noninvasive Submental Fat Compartment Treatment

BACKGROUND: KYBELLA, ATX-101, is an injectable form of sodium deoxycholic acid. It is currently the only Food and Drug Administration–approved injectable drug for the reduction of submental fat. OBJECTIVES: A literature review and discussion of the treatment of submental fat. RESULTS: KYBELLA is a w...

Descripción completa

Detalles Bibliográficos
Autor principal: Shamban, Ava T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Meeting Proceedings Cosmetic Bootcamp
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172481/
https://www.ncbi.nlm.nih.gov/pubmed/28018773
http://dx.doi.org/10.1097/GOX.0000000000001155
_version_ 1782484136581136384
author Shamban, Ava T.
author_facet Shamban, Ava T.
author_sort Shamban, Ava T.
collection PubMed
description BACKGROUND: KYBELLA, ATX-101, is an injectable form of sodium deoxycholic acid. It is currently the only Food and Drug Administration–approved injectable drug for the reduction of submental fat. OBJECTIVES: A literature review and discussion of the treatment of submental fat. RESULTS: KYBELLA is a well-tolerated alternative for the treatment of submental fat. CONCLUSIONS: KYBELLA is a safe and efficacious, first in class, injectable drug for the reduction of submental fat.
format Online
Article
Text
id pubmed-5172481
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-51724812016-12-23 Noninvasive Submental Fat Compartment Treatment Shamban, Ava T. Plast Reconstr Surg Glob Open Meeting Proceedings Cosmetic Bootcamp BACKGROUND: KYBELLA, ATX-101, is an injectable form of sodium deoxycholic acid. It is currently the only Food and Drug Administration–approved injectable drug for the reduction of submental fat. OBJECTIVES: A literature review and discussion of the treatment of submental fat. RESULTS: KYBELLA is a well-tolerated alternative for the treatment of submental fat. CONCLUSIONS: KYBELLA is a safe and efficacious, first in class, injectable drug for the reduction of submental fat. Wolters Kluwer Health 2016-12-14 /pmc/articles/PMC5172481/ /pubmed/28018773 http://dx.doi.org/10.1097/GOX.0000000000001155 Text en Copyright © 2016 The Author. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Meeting Proceedings Cosmetic Bootcamp
Shamban, Ava T.
Noninvasive Submental Fat Compartment Treatment
title Noninvasive Submental Fat Compartment Treatment
title_full Noninvasive Submental Fat Compartment Treatment
title_fullStr Noninvasive Submental Fat Compartment Treatment
title_full_unstemmed Noninvasive Submental Fat Compartment Treatment
title_short Noninvasive Submental Fat Compartment Treatment
title_sort noninvasive submental fat compartment treatment
topic Meeting Proceedings Cosmetic Bootcamp
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172481/
https://www.ncbi.nlm.nih.gov/pubmed/28018773
http://dx.doi.org/10.1097/GOX.0000000000001155
work_keys_str_mv AT shambanavat noninvasivesubmentalfatcompartmenttreatment

Ejemplares similares